Balanced news tone
News Sentiment
XVIVO sentiment intelligence
Xvivo Perfusion AB (publ) news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
55
Balanced news tone
13 relevant articles
News tone and price action are not far from neutral.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-1.7% over one week, -5.4% over four weeks, trend active, and near fair-value range.
AQR Capital Management no longer a public short seller in Xvivo Perfusion
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
82/100 classification
One-week reaction
-1.7%
Price digesting
Trend fit
Trend active
-5.4% over four weeks
Fair value
-13.8%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
3
Neutral
10
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
marketscreener.com
Direct company coverage
AQR Capital Management no longer a public short seller in Xvivo Perfusion
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 12:30
- Source
- marketscreener.com
marketscreener.com
Direct company coverage
Acadian Asset Management no longer a public short seller in Xvivo Perfusion
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 14:47
- Source
- marketscreener.com
marketscreener.com
Direct company coverage
Xvivo remains a buy according to SHB - stock now a growth play
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 27 Apr 2026 07:00
- Source
- marketscreener.com
Market source
Direct company coverage
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Apr 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Xvivo Perfusion Q4 Margin Compression Tests Bullish Growth Narrative
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Notice To Attend the Annual General Meeting in XVIVO Perfusion Ab (Publ)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Mar 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Delay in CE Approval for XVIVO's Perfusion Solution for Heart Preservation
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 28 Jul 2025 07:00
- Source
- Market source
Market source
Direct company coverage
XVIVO Honored with 2025 SACC-USA Business Award for Life-Saving Innovation and Growth in the U.S. Market
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jun 2025 07:00
- Source
- Market source
marketscreener.com
Direct company coverage
Xvivo Perfusion AB: Target Price Consensus and Analysts Recommendations | XVIVO | SE0004840718
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 24 Jan 2024 06:40
- Source
- marketscreener.com
Market source
Direct company coverage
XVIVO Completes the Acquisition of the Machine and Perfusion Business from Avionord S.r.l.
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 30 Nov 2022 08:00
- Source
- Market source
TradingView
Direct company coverage
XVIVO Forecast — Price Target — Prediction for 2027
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 27 Aug 2022 05:50
- Source
- TradingView
TradingView
Direct company coverage
Technical Analysis of Xvivo Perfusion AB (OMXSTO:XVIVO)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2018 07:33
- Source
- TradingView
TradingView
Direct company coverage
XVIVO Stock Price and Chart — OMXSTO:XVIVO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Apr 2018 02:06
- Source
- TradingView